Journal Article
. 2019 Apr;569(7755).
doi: 10.1038/s41586-019-1126-2.

LLGL2 rescues nutrient stress by promoting leucine uptake in ER+ breast cancer

Yasuhiro Saito 1 Lewyn Li 2 Etienne Coyaud 3 Augustin Luna 4 Chris Sander 4 Brian Raught 3 John M Asara 5 Myles Brown 2 Senthil K Muthuswamy 6 
Affiliations
  • PMID: 30996345
  •     17 citations

Abstract

Drosophila Lgl and its mammalian homologues, LLGL1 and LLGL2, are scaffolding proteins that regulate the establishment of apical-basal polarity in epithelial cells1,2. Whereas Lgl functions as a tumour suppressor in Drosophila1, the roles of mammalian LLGL1 and LLGL2 in cancer are unclear. The majority (about 75%) of breast cancers express oestrogen receptors (ERs)3, and patients with these tumours receive endocrine treatment4. However, the development of resistance to endocrine therapy and metastatic progression are leading causes of death for patients with ER+ disease4. Here we report that, unlike LLGL1, LLGL2 is overexpressed in ER+ breast cancer and promotes cell proliferation under nutrient stress. LLGL2 regulates cell surface levels of a leucine transporter, SLC7A5, by forming a trimeric complex with SLC7A5 and a regulator of membrane fusion, YKT6, to promote leucine uptake and cell proliferation. The oestrogen receptor targets LLGL2 expression. Resistance to endocrine treatment in breast cancer cells was associated with SLC7A5- and LLGL2-dependent adaption to nutrient stress. SLC7A5 was necessary and sufficient to confer resistance to tamoxifen treatment, identifying SLC7A5 as a potential therapeutic target for overcoming resistance to endocrine treatments in breast cancer. Thus, LLGL2 functions as a promoter of tumour growth and not as a tumour suppressor in ER+ breast cancer. Beyond breast cancer, adaptation to nutrient stress is critically important5, and our findings identify an unexpected role for LLGL2 in this process.

Nutritional issues in patients with cancer.
Duk Hwan Kim.
Intest Res, 2019 Oct 11; 17(4). PMID: 31597414    Free PMC article.
Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer.
Hua-Tao Wu, Hui-Ting Zhong, +4 authors, Jing Liu.
J Transl Med, 2020 Feb 06; 18(1). PMID: 32014049    Free PMC article.
Review.
Polarity proteins in oncogenesis.
Maria Fomicheva, Erica M Tross, Ian G Macara.
Curr Opin Cell Biol, 2019 Sep 12; 62. PMID: 31509786    Free PMC article.
Review.
Metabolomics Analysis of Laparoscopic Surgery Combined with Wuda Granule to Promote Rapid Recovery of Patients with Colorectal Cancer Using UPLC/Q-TOF-MS/MS.
Tao Wang, Yihua Xu, +6 authors, Zhiqiang Chen.
Evid Based Complement Alternat Med, 2020 Feb 28; 2020. PMID: 32104193    Free PMC article.
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer.
Marina Bacci, Nicla Lorito, +17 authors, Andrea Morandi.
Cell Rep, 2019 Jul 04; 28(1). PMID: 31269432    Free PMC article.
Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells.
Takanori Eguchi, Chiharu Sogawa, +6 authors, Stuart K Calderwood.
Cells, 2020 Mar 25; 9(3). PMID: 32204513    Free PMC article.
The Human Novel Gene LNC-HC Inhibits Hepatocellular Carcinoma Cell Proliferation by Sequestering hsa-miR-183-5p.
Xi Lan, Nan Wu, +13 authors, Shemin Lu.
Mol Ther Nucleic Acids, 2020 Apr 12; 20. PMID: 32278306    Free PMC article.
A Novel Model of Cancer Drug Resistance: Oncosomal Release of Cytotoxic and Antibody-Based Drugs.
Takanori Eguchi, Eman Ahmed Taha, Stuart K Calderwood, Kisho Ono.
Biology (Basel), 2020 Mar 11; 9(3). PMID: 32150875    Free PMC article.
Review.
Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints.
Kristian M Hargadon.
Clin Transl Med, 2020 Jun 09; 10(1). PMID: 32508018    Free PMC article.
Review.
Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer.
Lutfi H Alfarsi, Rokaya El Ansari, +5 authors, Andrew R Green.
Cancers (Basel), 2020 Jun 18; 12(6). PMID: 32545448    Free PMC article.
Genetic Profiles Affect the Biological Effects of Serine on Gastric Cancer Cells.
Jun Li, Hongzhang Xue, +6 authors, Yingyan Yu.
Front Pharmacol, 2020 Aug 28; 11. PMID: 32848786    Free PMC article.
Ykt6-dependent endosomal recycling is required for Wnt secretion in the Drosophila wing epithelium.
Karen Linnemannstöns, Leonie Witte, +8 authors, Julia Christina Gross.
Development, 2020 Jul 03; 147(15). PMID: 32611603    Free PMC article.
Circulating branched-chain amino acids and long-term risk of obesity-related cancers in women.
Deirdre K Tobias, Aditi Hazra, +7 authors, Samia Mora.
Sci Rep, 2020 Oct 08; 10(1). PMID: 33024201    Free PMC article.
Biomarker Analyses in Patients With Advanced Solid Tumors Treated With the LAT1 Inhibitor JPH203.
Naohiro Okano, Kiyomi Hana, +5 authors, Junji Furuse.
In Vivo, 2020 Sep 03; 34(5). PMID: 32871789    Free PMC article.
The role of amplified in breast cancer 1 in breast cancer: A meta-analysis.
Jianjing Hou, Jingting Liu, +2 authors, Jianhua Liao.
Medicine (Baltimore), 2020 Nov 13; 99(46). PMID: 33181714    Free PMC article.
Systematic Review.
CRIPTO antagonist ALK4L75A-Fc inhibits breast cancer cell plasticity and adaptation to stress.
Ozlen Balcioglu, Richard E Heinz, +11 authors, Benjamin T Spike.
Breast Cancer Res, 2020 Nov 15; 22(1). PMID: 33187540    Free PMC article.
Phosphorylation of Ykt6 SNARE Domain Regulates Its Membrane Recruitment and Activity.
Pradhipa Karuna M, Leonie Witte, +4 authors, Julia Christina Gross.
Biomolecules, 2020 Nov 20; 10(11). PMID: 33207719    Free PMC article.